13F HOLDINGS REPORT
KCK LTD.
Quarter ended Q4 2023 · Filed November 1, 2023 · Accession 0001012975-23-000447
Total Value
$70.4M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | NEUROPACE INC | NPCE | 5,621,111 | $54.7M | 77.70% |
| 2 | SIGHT SCIENCES INC | SGHT | 4,646,866 | $15.7M | 22.25% |
| 3 | AILERON THERAPEUTICS INC | RNTX | 22,341 | $33,958 | 0.05% |